PROSIGHT MANAGEMENT, LP – BioCryst Pharmaceuticals, Inc. Transaction History
PROSIGHT MANAGEMENT, LP portfolio value:
$1.43M
portfolio value
PROSIGHT MANAGEMENT, LP quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -35.59% | -62.88K shares | -435K | $12.6 | 113.8K |
| Q2 2022 | share | Increase | 0.00% | 176.68K shares | 1.86M | $10.58 | 176.68K |